<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034367</url>
  </required_header>
  <id_info>
    <org_study_id>5801151</org_study_id>
    <nct_id>NCT05034367</nct_id>
  </id_info>
  <brief_title>Reference Ranges for the Cough Responsiveness to Inhaled Mannitol</brief_title>
  <official_title>Reference Ranges for the Cough Responsiveness to Inhaled Mannitol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>John Hunter Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Prince Alfred Hospital, Sydney, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cough is the most common reason why people seek medical attention in developed countries. The&#xD;
      main mechanisms for prolonged cough are hypersensitivity of the cough reflex arc, sputum&#xD;
      production, and constriction of the airway smooth muscles. Recognition of the mechanism in&#xD;
      each cough patient is essential for the efficient management of prolonged cough. At present,&#xD;
      there are no feasible tests for everyday clinical work to recognize cough reflex arc&#xD;
      hypersensitivity.&#xD;
&#xD;
      Mannitol test was originally developed for asthma diagnostics. We have recently shown that it&#xD;
      can also be used to investigate hypersensitive cough reflex arc. The purpose of the present&#xD;
      study is to create reference ranges for normal cough responsiveness to inhaled mannitol.&#xD;
      Without them, the test cannot be utilized in everyday clinical work. For that purpose we will&#xD;
      perform mannitol test in 140 subjects, who are at least 18 years old and without any chronic&#xD;
      respiratory symptoms or disorders. The subjects will be recruited in three centers:&#xD;
      University of Eastern Finland and two Australian hospitals: John Hunter Hospital and Royal&#xD;
      Prince Alfred Hospital.The material will be collected 1.9.2021-31.12.2022. We apply funding&#xD;
      for both personnel and material expences, to carry out this study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cough-to-dose ratio</measure>
    <time_frame>Coughs are recorded during the 60 seconds after each mannitol dose</time_frame>
    <description>calculated as the number of coughs per 100 mg of total cumulative dose of mannitol</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Healthy persons</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The responses of the healthy subjects are utilized to create reference ranges for a normal cough response to mannitol</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Mannitol challenge</intervention_name>
    <description>Inhalation challenge with dry powder of mannitol with a maximal cumulative dose of 635 mg</description>
    <arm_group_label>Healthy persons</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18 years or older&#xD;
&#xD;
          -  capable to understand the purpose of the study&#xD;
&#xD;
          -  female/male ratio approximately 50%/50% in both of the following age groups:&#xD;
&#xD;
          -  50% aged 18- 50 yrs, and 50 % aged 51 - 90 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current daily smoking&#xD;
&#xD;
          -  Ex-smoking with a greater than 10 pack years' daily smoking history or with stopping&#xD;
             of daily smoking less than one year ago&#xD;
&#xD;
          -  Pregnancy and breastfeeding&#xD;
&#xD;
          -  A doctor's diagnosis of any respiratory diseases, including both upper and lower&#xD;
             airway diseases, lung parenchymal diseases and the sleep apnoea syndrome&#xD;
&#xD;
          -  A doctor's diagnosis of gastro-oesophageal reflux disease or symptoms suggestive of it&#xD;
&#xD;
          -  Current use of angiotensin-converting enzyme inhibitors&#xD;
&#xD;
          -  Upper respiratory tract infection ('flu') within 4 weeks&#xD;
&#xD;
          -  Any current (within 4 weeks) cough 8&#xD;
&#xD;
          -  Chronic (over 2 months' duration) cough during the last 12 months&#xD;
&#xD;
          -  Wheezing during the last 12 months&#xD;
&#xD;
          -  Attacks of shortness of breath or cough at night during the last 12 months&#xD;
&#xD;
          -  Symptoms of rhinitis in a prolonged fashion during the last 12 months&#xD;
&#xD;
          -  Heartburn or regurgitation once a week or more often during the last 3 months&#xD;
&#xD;
          -  Abnormal anatomy of the respiratory organs, which may affect the deposition of the&#xD;
             mannitol powder&#xD;
&#xD;
          -  Any previous operations to the respiratory organs that can affect the deposition of&#xD;
             the mannitol powder&#xD;
&#xD;
          -  Unable to provide written informed consent to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Heikki O Koskela, MD</last_name>
    <phone>+358 447172795</phone>
    <email>heikki.koskela@kuh.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hanna M Nurmi, MD</last_name>
    <phone>+358 447179973</phone>
    <email>hanna.nurmi@kuh.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>Newcastle</city>
        <state>New South Wales</state>
        <zip>2305</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John D Brannan, PhD</last_name>
      <phone>+61 435 206 232</phone>
      <email>john.brannan@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Wong, PhD</last_name>
      <phone>+61 2 9515 6652</phone>
      <email>keith.wong@sydney.edu.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heikki O Koskela, MD</last_name>
      <phone>+358 447172795</phone>
      <email>heikki.koskela@kuh.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 1, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Heikki Koskela</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

